<DOC>
	<DOCNO>NCT02834429</DOCNO>
	<brief_summary>The aim study assess clinical utility whole blood transglutaminase-based rapid test current serological test gold standard duodenal biopsy . The investigator recruit patient ( n=1000 ) endoscopy department Royal Hallamshire Hospital , Sheffield , United Kingdom ( UK ) . The patient recruit study already refer consultation gastroscopy . In addition , patient already serologically test IgA TTG , EMA total IgA immunoglobulin level ( per normal clinical practice ) . All duodenal biopsy specimen fix buffered formalin embed paraffin wax . Standard , 3μm thick section three level stain haematoxylin eosin report routinely . Additionally , biopsy demonstrate increased intraepithelial lymphocyte ( change compatible diagnostic coeliac disease ) stain KiRAS CD4/CD8 marker coeliac disease .</brief_summary>
	<brief_title>Pre-endoscopy Serological Testing Coeliac Disease ; Novel Approach Using Rapid Antibody Testing</brief_title>
	<detailed_description>Coeliac disease common chronic inflammatory bowel condition encounter physician . Internationally prevalence estimate serological screening healthy volunteer 0.5-1.0 % . Historically , patient adult coeliac disease complain symptom suggestive mal-absorption , diarrhoea , weight loss anaemia . This manner presentation describe classical ( typical ) form . Failure recognise disease may due insidious nature presentation . Individuals undiagnosed coeliac disease may numerous hospital attendance , prior diagnosis . Although presentation patient coeliac disease may protean , serological marker provide cheap non-invasive method clinician primary secondary care initially recognise patient may coeliac disease . The aim study assess clinical utility whole blood transglutaminase-based rapid test current serological test gold standard duodenal biopsy . Methods : Study design Participants Group 1 multicentre retrospective analysis patient anaemia attend gastroscopy duodenal biopsy four UK hospital ( Addenbrooke 's , Bradford , Hull Whipps Cross ) 12 month period range 2012 2014 . The availability coeliac serology prior gastroscopy review . Group 2 prospective study compare sensitivity Simtomax conventional serology iron deficient cohort . We prospectively recruit 133 consecutive patient ( age range : 18-89 year , median 53 ) iron deficiency without anaemia attend single coeliac disease research endoscopy list tertiary referral centre Royal Hallamshire Hospital 2013 2015 . All recruit patient consent study prior gastroscopy . The patient concurrently undertook point-of-care test , Simtomax , conventional coeliac serology ( IgA-TTG , IgA-EMA ) total IgA level endoscopy unit . All patient gastroscopy quadrantic duodenal biopsy second part duodenum least one duodenal bulb biopsy . Patients exclude study know coeliac disease gluten free diet . Patients coagulopathy , active gastrointestinal bleeding suspect carcinoma observe examination also exclude . Clinical information patient available endoscopist , however endoscopist blind result Simtomax test . Group 3 retrospective histological analysis patient attend separate non-coeliac specific iron deficiency anaemia clinic Northern General Hospital 2013-2014 . We review duodenal histology hospital case note determine yield alternative cause coeliac disease context iron deficiency anaemia . Point-of-care test , Simtomax : Simtomax point-of-care test coeliac disease manufacture Augurix Diagnostics , Switzerland . It detect IgA IgG antibody DGP , well total IgA level . The assay base lateral flow immunochromatography use colloidal gold antihuman antibodies signal detector . A sample 25 μl capillary venous blood require obtain simple finger prick technique . The assay also perform use plasma sample either ethylenediaminetetraacetic acid ( EDTA ) heparin well separate serum sample , although small sample volume 20 μl require . The blood sample apply test device , follow application 5 drop provide buffer solution . The result read 10 minute . Positive result indicate presence solid red test line IgA and/or IgG-DGP positivity . A second single red line indicate presence IgA . An in-built red control line ensure correctly functioning test . Serology : Total IgA measure Behring BN2 nephelometer . IgA-TTG antibody evaluate use enzyme-linked immunosorbent assay kit ( Aesku Diagnostics , Wendelsheim , Germany ) . An IgA-TTG titre &gt; 15 U/ml 20/5/2014 , new cut level &gt; 9 U/ml 20/5-11/12/2014 , &gt; 7 U/ml 12/12/2014 onwards , regard positive per manufacturer 's guidance . IgA-EMA detect immunofluorescence primate oesophagus section ( Binding Site , Birmingham , UK ) . Biopsies histology In total , least five biopsy take duodenum , include least one duodenal bulb , biopsy fix formalin time gastroscopy . Specimens process , orientate embedded paraffin wax pathology department . Standard 3 µm thick section three level stain haematoxylin eosin , report routinely gastrointestinal histopathologists without knowledge Simtomax result . Villous atrophy grade accord modify Marsh criterion . Diagnosis coeliac disease : The presence villous atrophy ( Marsh 3a-3c ) histology positive IgA-EMA IgA-TTG require diagnosis coeliac disease . In case seronegative villous atrophy , human leucocyte antigen ( HLA ) genotyping perform , negative HLA DQ2 DQ8 phenotype use rule coeliac disease . Supporting information family history response gluten free diet also take account .</detailed_description>
	<mesh_term>Celiac Disease</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Patients age 18 year undergo clinically indicate gastroscopy biopsy coeliac serology test Patients coagulopathy ( INR &gt; 1.3 Platelets &lt; 80 ) Active gastrointestinal bleeding identify endoscopy suspect carcinoma identify gastroscopy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>